The cell fate determination factor DACH1 is expressed in estrogen receptor-α-positive breast cancer and represses estrogen receptor-α signaling

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5752-5760

  Popov, Vladimir M ^a   Zhou, Jie ^a   Shirley, L Andrew ^b   Quong, Judy ^a   Yeow, Wen Shuz ^a   Wright, Jennifer A ^a   Wu, Kongming ^a   Rui, Hallgeir ^a   Vadlamudi, Ratna K ^c   Jiang, Jie ^a   Kumar, Rakesh ^d   Wang, Chenguang ^a   Pestell, Richard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLUTAMIC ACID; LEUCINE; LEUCINE RICH PROTEIN 1; PROLINE; PROTEIN DACHSHUND H1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; EYE PROTEINS; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MICROSCOPY, CONFOCAL; MUTATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 67650996915     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3992     Document Type: Article

References (50)

1. Dickson RB, Pestell RG, Lippman ME. Molecular biology of breast cancer. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1399-414.
2. Khan SA, Rogers MA, Obando JA, Tamsen A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 1994;54:993-7.
3. Ali S, Coombes RC. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2002;2:101-12.
4. Madureira PA, Varshochi R, Constantinidou D, et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor a in breast cancer cells. J Biol Chem 2006;281:25167-76.
5. Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004;75:807-21.
6. Pedram A, Razandi M, Wallace DC, Levin ER. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 2006;17:2125-37.
7. Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006;20:1996-2009.
8. Htu n H, Holth LT, Walker D, Davie JR, Hager GL. Direct visualization of the human estrogen receptor a reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 1999;10:471-86.
9. Masuhiro Y,Mezaki Y, Sakari M, et al. Splicing potentiation by growth factor signals via estrogen receptor phosphorylation. Proc Natl Acad Sci U S A 2005;102:8126-31.
10. Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 2005;239:27-36.
11. Coombes RC, Powles TJ, Berger U, et al. Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet 1987;2:701-3.
12. Taylor RE, Powles TJ, Humphreys J, et al. Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer 1982;45:80-5.
13. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007;87:905-31.
14. Whittle JR, Powell MJ, Popov VM, Shirley LA, Wang C, Pestell RG. Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation. Trends Endocrinol Metab 2007;18:356-64.
15. Green AR, Burney C, Granger CJ, et al. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome. Breast Cancer Res Treat 2008;110:427-37.
16. Vadlamudi RK, Wang RA, Mazumdar A, et al. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor α. J Biol Chem 2001;276:38272-9.
17. Mishra SK, Talukder AH, Gururaj AE, et al. Upstream determinants of estrogen receptor-α regulation of metastatic tumor antigen 3 pathway. J Biol Chem 2004;279:32709-15.
18. Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK. Cloning and functional characterization of PELP1/MNAR promoter. Gene 2004;330:115-22.
19. Wu K, Li A, Rao M, et al. DACH1 is a cell fate determination factor that inhibits Cyclin D1 and breast tumor growth. Mol Cell Biol 2006;26:7116-29.
20. Mardon G, Solomon NM, Rubin GM. Dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 1994;120:3473-86.
21. Shen W, Mardon G. Ectopic eye development in drosophila induced by directed dachsund expression. Development 1997;124:45-52.
22. Silver SJ, Rebay I. Signaling circuitries in development: insights from the retinal determination gene network. Development 2005;132:3-13.
23. Keisman EL, Baker BS. The Drosophila sex determination hierarchy modulates wingless and decapentaplegic signaling to deploy dachshund sex-specifically in the genital imaginal disc. Development 2001;128:1643-56.
24. Wu K, Yang Y, Wang C, et al. DACH1 inhibits TGF-β signaling through binding Smad4. J Biol Chem 2003;278:51673-84.
25. Wang C, Fu M, Angeletti RH, et al. Direct acetylation of the estrogen receptor a hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 2001;276:18375-83.
26. Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Cancer Res 2004;64:6416-23.
27. Balasenthil S, Vadlamudi RK. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. J Biol Chem 2003;278:22119-27.
28. Fu M, Wang C, Reutens AT, et al. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 2000;275:20853-60.
29. Fu M, Wang C, Wang J, et al. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol 2002;22:3373-88.
30. Fu M, Wang C, Wang J, et al. Acetylation of the androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 2003;23:8563-75.
31. Lee RJ, Albanese C, Fu M, et al. Cyclin D1 is required for transformation by activated Neuand is induced through an E2F-dependent signaling pathway. Mol Cell Biol 2000;20:672-83.
32. Wu K, Liu M, Li A, et al. The cell fate determination factor DACH1 inhibits c-Jun induced contact-independent growth. Mol Biol Cell 2007;18:755-67.
33. Rui H, LeBaron MJ. Creating tissue microarrays by cutting-edge matrix assembly. Expert Rev Med Devices 2005;2:673-80.
34. Fu M, Rao M, Wu K, et al. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J Biol Chem 2004;279:29436-49.
35. Boyan BD, Sylvia VL, Frambach T, et al. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology 2003;144:1812-24.
36. Liu MM, Albanese C, Anderson CM, et al. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 2002;277:24353-60.
37. Wu K, Katiyar S, Li A, et al. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proc Natl Acad Sci U S A 2008;105:6924-9.
38. King MC, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001;286:2251-6.
39. Webb P, Anderson CM, Valentine C, et al. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 2000;14:1976-85.
40. Hinojos CA, Sharp ZD, Mancini MA. Molecular dynamics and nuclear receptor function. Trends Endocrinol Metab 2005;16:12-8.
41. Heanue TA, Davis RJ, Rowitch DH, et al. Dach1, a vertebrate homologue of drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax6 and Eya genes. Mech Dev 2002;111:75-87.
42. Ikeda K, Watanabe Y, Sno H, Ohto I, Kawakami K. Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein. Mol Cell Biol 2002;22:6759-66.
43. Li X, Oghi KA, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003;426:247-54.
44. Vadlamudi RK, Manavathi B, Balasenthil S, et al. Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005;65:7724-32.
45. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47.
46. Mishra SK, Mazumdar A, Vadlamudi RK, et al. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-a transactivation functions. J Biol Chem 2003;278:19209-19.
47. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A 2002;99:14783-8.
48. Manavathi B, Kumar R. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol 2006;207:594-604.
49. Greger JG, Fursov N, Cooch N, et al. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol Cell Biol 2007;27:1904-13.
50. Choi YB, Ko JK, Shin J. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J Biol Chem 2004;279:50930-41.